Innovative Technologies parts with founders:
This article was originally published in Clinica
Keith Gilding, former CEO of Innovative Technologies and Diana Mitchell, his wife, have resigned from the company's board. Along with four others they started Innovative as a biomaterials company in 1991. Disappointing sales figures forced Mr Gilding to stand down. Roy Smith who joined the company as deputy CEO and general manager in April takes over as CEO. Mr Gilding presided over a number of distribution agreements and the acquisition of the unprofitable woundcare division of Polymedica. Shares in Innovative rose by 12.5p to 182.5p on the news.
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.